chronic prurigo
Conditions
Interventions
Treatment
Sponsors
Tsuyoshi Namiki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) a patient with chronic prurigo 2) a patient who was not improved by oral anti-histamine drug and topical steroid 3) a patient at age 20 or over 4) a patient who fully understand and agree to join this clinical study 5) outpatient
Exclusion criteria
Exclusion criteria: 1) a patient orally administrated immune suppressants or high-dose steroid within three months 2) a patient who undergo UV photo therapy 3) a patinet who was treated with anti-IgE antibody within four months 4) a patient suffering from severe visceral diseases, autoimmune diseases, blood dosorders, and mental disorders 5) a patient who is pregnant or breast-feed 6) a patinet who is infected with parasite 7) a patient who is sensitive to this medication 6) a patient judged inadequate to this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| skin symptom | — |
Secondary
| Measure | Time frame |
|---|---|
| itch, blood examination | — |
Contacts
Public ContactTsukasa Ugajin
Tokyo Medical and Dental University
Outcome results
None listed